Dopamine System Dysregulation by the Ventral Subiculum as the Common Pathophysiological Basis for Schizophrenia Psychosis, Psychostimulant Abuse, and Stress
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The dopamine system is under multiple forms of regulation, and in turn provides effective modulation of system responses. Dopamine neurons are known to exist in several states of activity. The population activity, or the proportion of dopamine neurons firing spontaneously, is controlled by the ventral subiculum of the hippocampus. In contrast, burst firing, which is proposed to be the behaviorally salient output of the dopamine system, is driven by the brainstem pedunculopontine tegmentum (PPTg). When an animal is exposed to a behaviorally salient stimulus, the PPTg elicits a burst of action potentials in the dopamine neurons. However, this bursting only occurs in the portion of the dopamine neuron population that is firing spontaneously. This proportion is regulated by the ventral subiculum. Therefore, the ventral subiculum provides the gain, or the amplification factor, for the behaviorally salient stimulus. The ventral subiculum itself is proposed to carry information related to the environmental context. Thus, the ventral subiculum will adjust the responsivity of the dopamine system based on the needs of the organism and the characteristics of the environment. However, this finely tuned system can be disrupted in disease states. In schizophrenia, a disruption of interneuronal regulation of the ventral subiculum is proposed to lead to an overdrive of the dopamine system, rendering the system in a constant hypervigilant state. Moreover, amphetamine sensitization and stressors also appear to cause an abnormal dopaminergic drive. Such an interaction could underlie the risk factors of drug abuse and stress in the precipitation of a psychotic event. On the other hand, this could point to the ventral subiculum as an effective site of therapeutic intervention in the treatment or even the prevention of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Place units in the hippocampus of the freely moving rat
O'Keefe, J. (1976) · Experimental Neurology · doi:10.1016/0014-4886(76)90055-8 · Cited by 1,836
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
Self-citationAntipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
The psychology and neurobiology of addiction: an incentive–sensitization view
Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507 · cited 2×
“…administered amphetamine or cocaine for a period of 5 days and then is withdrawn from the amphetamine for an equivalent period, the rat will show an abnormally large, or sensitized, response when tested with a single dose of amphetamine (Post 1980; Robinson and Berridge 2000; Lodge and Grace 2008).”
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399 · cited 2×
“Thus, studies by Murray and collaborators (Arseneault et al. 2002) have shown that abuse of cannabis, particularly during adolescence, can render an individual more susceptible to schizophrenia, particularly when this is combined with other risk factors such as a polymorphism at the site for catechol-O-methyl-transfer…”
Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort
JONES, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90569-x · Cited by 1,353 · cited 2×
“…to schizophrenia, or alternately can lead to exacerbation of psychosis or relapse in those individuals in which the schizophrenia is in remission, including stress, perinatal factors, environmental factors, and drug abuse (Jones et al. 1994; Hultman et al. 1999; McDonald and Murray 2000).”
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218 · cited 2×
“Interestingly, although GABAergic neurons that contain parvalbumin do not express cannabinoid receptors (Katona et al. 1999; Marsicano and Lutz 1999; Hajos et al. 2000), these neurons are potently modulated by cannabinoid-receptor containing cholecystokinin (CCK)-expressing (Marsicano and Lutz 1999; Tsou et al.”
Floresco, S. B., West, A. R., Ash, B., Moore, H., & Grace, A. A. (2003) · Nature Neuroscience · doi:10.1038/nn1103 · Cited by 1,106
Self-citationAbercrombie, E. D., Keefe, K. A., DiFrischia, D. S., & Zigmond, M. J. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09224.x · Cited by 1,106
Hippocampal damage associated with prolonged glucocorticoid exposure in primates
Sapolsky, R., Uno, H., Rebert, C., & Finch, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-09-02897.1990 · Cited by 1,103
Marsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937 · cited 4×
“Interestingly, although GABAergic neurons that contain parvalbumin do not express cannabinoid receptors (Katona et al. 1999; Marsicano and Lutz 1999; Hajos et al. 2000), these neurons are potently modulated by cannabinoid-receptor containing cholecystokinin (CCK)-expressing (Marsicano and Lutz 1999; Tsou et al.”
InfluentialMeyer-Lindenberg, A. S., Olsen, R. K., Kohn, P. D., Brown, T., Egan, M. F., Weinberger, D. R., & Berman, K. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.379 · Cited by 574
Lodge, D. J., Behrens, M. M., & Grace, A. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5419-08.2009 · Cited by 488 · cited 5×
“The source of this hyperactivity in the ventral subiculum appears to correlate with a loss of parvalbumin GABAergic interneuron staining observed in the ventral subiculum and in the prefrontal cortex of MAM rats (Lodge et al., 2009) as well as in schizophrenia patients (Lewis et al.”
InfluentialSelf-citationZhang, Z. J., & Reynolds, G. P. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00188-8 · Cited by 460 · cited 2×
“2009) as well as in schizophrenia patients (Lewis et al. 2001; Zhang and Reynolds 2002).”
Finlay, J. M., Zigmond, M. J., & Abercrombie, E. D. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00331-x · Cited by 434 · cited 2×
“Stress itself has been shown to increase levels of DA in postsynaptic targets (Abercrombie et al. 1989; Finlay et al. 1995; Castro and Zigmond 2001).”
Zweifel, L. S., Parker, J. G., Lobb, C. J., Rainwater, A., Wall, V. Z., Fadok, J. P., Darvas, M., Kim, M. J., Mizumori, S. J. Y., Paladini, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813415106 · Cited by 426 · cited 3×
“Burst firing in DA neurons occurs via stimulation of N-methyl-D-aspartate (NMDA) receptors on the DA neuron somatodendritic tree (Chergui et al. 1993; Zweifel et al. 2009).”
Neuroimaging studies of the hippocampus in schizophrenia
Heckers, S. (2001) · Hippocampus · doi:10.1002/hipo.1068 · Cited by 420 · cited 1×
“Moreover, there is increasing evidence that the anterior hippocampus (the human homolog of the ventral subiculum) is overactive in schizophrenia patients (Malaspina et al. 1999; Kegeles et al. 2000; Heckers 2001; Medoff et al. 2001; Meyer-Lindenberg et al. 2005).”
Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning
Rosenkranz, J. A., & Grace, A. A. (2002) · Nature · doi:10.1038/417282a · Cited by 348 · cited 2×
“Moreover, the prefrontal cortex has been shown to be a potent regulator of the stress response, in part via attenuation of responses in the amygdala ( Rosenkranz and Grace 2002a, b; Rosenkranz et al. 2003), which is the brain region in which fear and anxiety are expressed (LeDoux 2000).”
Self-citationRosenkranz, J. A., Moore, H., & Grace, A. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11054.2003 · Cited by 344
Self-citationCannabinoids reveal importance of spike timing coordination in hippocampal function
Robbe, D., Montgomery, S. M., Thome, A., Rueda-Orozco, P. E., McNaughton, B. L., & Buzsaki, G. (2006) · Nature Neuroscience · doi:10.1038/nn1801 · Cited by 333 · cited 1×
“Indeed, studies show that cannabinoid agonists can disrupt the ability of parvalbumin interneuron-driven gamma rhythmicity (Hajos et al. 2000; Robbe et al. 2006).”
Amphetamine psychosis: Behavioral and biochemical aspects
Angrist, B., Sathananthan, G., Wilk, S., & Gershon, S. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90064-8 · Cited by 326
Increased Occupancy of Dopamine Receptors in Human Striatum during Cue-Elicited Cocaine Craving
Wong, D. F., Kuwabara, H., Schretlen, D. J., Bonson, K. R., Zhou, Y., Nandi, A., Brašić, J. R., Kimes, A. S., Maris, M. A., Kumar, A., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301194 · Cited by 311
Self-citationPre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008353 · Cited by 295 · cited 2×
“Thus, other drugs of abuse, such as psychostimulants, are known to exacerbate the symptoms of schizophrenia (Angrist et al. 1975), and abuse of these drugs can render an individual more susceptible to transition to psychosis (Chen et al. 2003).”
The subiculum: what it does, what it might do, and what neuroanatomy has yet to tell us
O'Mara, S. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00446.x · Cited by 285 · cited 3×
“Interestingly, the ventral subiculum is posited as a primary central integrator of the stress response (O’Mara 2005; Herman and Mueller 2006).”
Lodge, D. J., & Grace, A. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300963 · Cited by 280
Self-citationRestraint increases dopaminergic burst firing in awake rats
Anstrom, K. K., & Woodward, D. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300730 · Cited by 181 · cited 2×
“activating stimulus, such as reward (Schultz 1998; Anstrom and Woodward 2005; Zweifel et al. 2009).”
The phasic reward signal of primate dopamine neurons
Schultz, W. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60841-8 · Cited by 169 · cited 2×
“activating stimulus, such as reward (Schultz 1998; Anstrom and Woodward 2005; Zweifel et al. 2009).”
Karson, M. A., Tang, A.-H., Milner, T. A., & Alger, B. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5264-08.2009 · Cited by 135 · cited 2×
“Interestingly, although GABAergic neurons that contain parvalbumin do not express cannabinoid receptors (Katona et al. 1999; Marsicano and Lutz 1999; Hajos et al. 2000), these neurons are potently modulated by cannabinoid-receptor containing cholecystokinin (CCK)-expressing (Marsicano and Lutz 1999; Tsou et al. 1999)…”
Cited by
Teicher, M. H., Anderson, C. M., & Polcari, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115396109 · Cited by 639
“These actions appear to take place through a ventral subiculum-nucleus accumbens pathway (51, 52).”
BackgroundInfluentialA neoHebbian framework for episodic memory; role of dopamine-dependent late LTP
Lisman, J., Grace, A. A., & Duzel, E. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.07.006 · Cited by 465
Self-citationCell-Type-Specific Control of Brainstem Locomotor Circuits by Basal Ganglia
Roseberry, T. K., Lee, A. M., Lalive, A. L., Wilbrecht, L., Bonci, A., & Kreitzer, A. C. (2016) · Cell · doi:10.1016/j.cell.2015.12.037 · Cited by 395
Stratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.010 · Cited by 186
Allen, P., Luigjes, J., Howes, O. D., Egerton, A., Hirao, K., Valli, I., Kambeitz, J., Fusar-Poli, P., Broome, M., & McGuire, P. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr194 · Cited by 129
Metadata
- Authors
- Grace, A. A.
- Venue
- Neurotoxicity Research
- Published
- 2010-02-09
- Volume
- 18
- Issue
- 3-4
- Pages
- 367-376
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- OpenAlex
- W2089415354
- Cited by
- 98
- References
- 32
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.